Skip to content 
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified. more
| Time Frame | LABU | S&P500 |
|---|---|---|
| 1-Week Return | 0.53% | 0.35% |
| 1-Month Return | -14.94% | -0.27% |
| 3-Month Return | 17.31% | 2.29% |
| 6-Month Return | 82.74% | 16.11% |
| 1-Year Return | 212.76% | 14.16% |
| 3-Year Return | 243.28% | 76.36% |
| 5-Year Return | -78.25% | 75.43% |
| 10-Year Return | -74.88% | 254.13% |
| Stock name | Ticker | Weight |
|---|---|---|
 SPSIBI SWAP ASSET LEG (SPSIBIUBL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIUBL. | 19.39% |
 SPSIBI SWAP ASSET LEG (SPSIBIMLL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIMLL. | 17.66% |
 SPSIBI SWAP ASSET LEG (SPSIBIBCL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBCL. | 14.02% |
 SPSIBI SWAP ASSET LEG (SPSIBIJPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIJPL. | 11.89% |
 GOLDMAN FINL SQ TRSRY INST 506 | GOLDMAN.FINL.SQ.TRSRY.INST.506 | 4.15% |
 SPSIBI SWAP ASSET LEG (SPSIBICTL) | SPSIBI.SWAP.ASSET.LEG..SPSIBICTL. | 3.11% |
 DREYFUS GOVT CASH MAN INS | DREYFUS.GOVT.CASH.MAN.INS | 2.94% |
 SPSIBI SWAP ASSET LEG (SPSIBIBPL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIBPL. | 1.61% |
 SPSIBI SWAP ASSET LEG (SPSIBIGSL) | SPSIBI.SWAP.ASSET.LEG..SPSIBIGSL. | 1.05% |
 MODERNA INC | MRNA | 0.75% |
 TWIST BIOSCIENCE CORP | TWST | 0.5% |
 NATERA INC | NTRA | 0.38% |
 HALOZYME THERAPEUTICS INC | HALO | 0.37% |
 KYMERA THERAPEUTICS INC | KYMR | 0.35% |
 ORUKA THERAPEUTICS INC | ORKA | 0.35% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.34% |
 ROIVANT SCIENCES LTD | ROIV | 0.33% |
 REVOLUTION MEDICINES INC | RVMD | 0.32% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.32% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.32% |
 CG ONCOLOGY INC | CGON | 0.32% |
 DIANTHUS THERAPEUTICS INC | DNTH | 0.32% |
 INSMED INC | INSM | 0.32% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.31% |
 VAXCYTE INC | PCVX | 0.31% |
 REGENERON PHARMACEUTICALS | REGN | 0.31% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.3% |
 GILEAD SCIENCES INC | GILD | 0.29% |
 SPYRE THERAPEUTICS INC | SYRE | 0.29% |
 TG THERAPEUTICS INC | TGTX | 0.28% |
 RELAY THERAPEUTICS INC | RLAY | 0.28% |
 INCYTE CORP | INCY | 0.28% |
 VERTEX PHARMACEUTICALS INC | VRTX | 0.28% |
 ABBVIE INC | ABBV | 0.28% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.27% |
 ERASCA INC | ERAS | 0.27% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.27% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.27% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.27% |
 AMGEN INC | AMGN | 0.26% |
 BIOGEN INC | BIIB | 0.26% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.26% |
 EXELIXIS INC | EXEL | 0.26% |
 KRYSTAL BIOTECH INC | KRYS | 0.26% |
 GRAIL INC | GRAL | 0.26% |
 VIKING THERAPEUTICS INC | VKTX | 0.25% |
 CRISPR THERAPEUTICS AG | CRSP | 0.25% |
 ALKERMES PLC | ALKS | 0.25% |
 COGENT BIOSCIENCES INC | COGT | 0.25% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.25% |
 CYTOKINETICS INC | CYTK | 0.25% |
 UNIQURE NV | QURE | 0.24% |
 BRIDGEBIO PHARMA INC | BBIO | 0.24% |
 SELLAS LIFE SCIENCES GROUP I | SLS | 0.24% |
 IMMUNITYBIO INC | IBRX | 0.24% |
 IMMUNOVANT INC | IMVT | 0.22% |
 CELCUITY INC | CELC | 0.22% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.22% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.22% |
 PTC THERAPEUTICS INC | PTCT | 0.22% |
 UNITED THERAPEUTICS CORP | UTHR | 0.22% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.21% |
 VIRIDIAN THERAPEUTICS INC | VRDN | 0.21% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.21% |
 VERA THERAPEUTICS INC | VERA | 0.2% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 0.2% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.19% |
 CELLDEX THERAPEUTICS INC | CLDX | 0.19% |
 BEAM THERAPEUTICS INC | BEAM | 0.19% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.19% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.18% |
 HYPERLIQUID STRATEGIES | PURR | 0.17% |
 DYNE THERAPEUTICS INC | DYN | 0.17% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.17% |
 NOVAVAX INC | NVAX | 0.17% |
 IMMUNOME INC | IMNM | 0.17% |
 DENALI THERAPEUTICS INC | DNLI | 0.17% |
 ADMA BIOLOGICS INC | ADMA | 0.17% |
 TANGO THERAPEUTICS INC | TNGX | 0.16% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.16% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.16% |
 DISC MEDICINE INC | IRON | 0.16% |
 ARCUS BIOSCIENCES INC | RCUS | 0.15% |
 PALVELLA THERAPEUTICS INC | PVLA | 0.15% |
 NURIX THERAPEUTICS INC | NRIX | 0.15% |
 CAREDX INC | CDNA | 0.15% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.15% |
 IONIS PHARMACEUTICALS INC | IONS | 0.15% |
 VERACYTE INC | VCYT | 0.14% |
 PRECIGEN INC | PGEN | 0.13% |
 VIR BIOTECHNOLOGY INC | VIR | 0.12% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.12% |
 KODIAK SCIENCES INC | KOD | 0.12% |
 VERICEL CORP | VCEL | 0.11% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.11% |
 XENCOR INC | XNCR | 0.11% |
 BIOHAVEN LTD | BHVN | 0.11% |
 STOKE THERAPEUTICS INC | STOK | 0.11% |
 ZENAS BIOPHARMA INC | ZBIO | 0.1% |
 ANAPTYSBIO INC | ANAB | 0.1% |
 ABSCI CORP | ABSI | 0.1% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.1% |
 INHIBRX BIOSCIENCES INC | INBX | 0.1% |
 VOR BIOPHARMA INC | VOR | 0.09% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.09% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.09% |
 REPLIMUNE GROUP INC | REPL | 0.09% |
 KURA ONCOLOGY INC | KURA | 0.08% |
 TYRA BIOSCIENCES INC | TYRA | 0.08% |
 AVALO THERAPEUTICS INC | AVTX | 0.08% |
 GOLDMAN SACHS FIN GOV 465 INSTITUT | GOLDMAN.SACHS.FIN.GOV.465.INSTITUT | 0.08% |
 JANUX THERAPEUTICS INC | JANX | 0.07% |
 MANNKIND CORP | MNKD | 0.07% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.07% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.07% |
 GERON CORP | GERN | 0.07% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.06% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.06% |
 ALTIMMUNE INC | ALT | 0.06% |
 JADE BIOSCIENCES INC | JBIO | 0.06% |
 ARDELYX INC | ARDX | 0.06% |
 IMMIX BIOPHARMA INC | IMMX | 0.06% |
 VERASTEM INC | VSTM | 0.06% |
 ANNEXON INC | ANNX | 0.06% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.06% |
 BICARA THERAPEUTICS INC | BCAX | 0.06% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.05% |
 SOLID BIOSCIENCES INC | SLDB | 0.05% |
 CANDEL THERAPEUTICS INC | CADL | 0.05% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.05% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.05% |
 SANA BIOTECHNOLOGY INC | SANA | 0.05% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.05% |
 CAPRICOR THERAPEUTICS INC | CAPR | 0.04% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.04% |
 DAMORA THERAPEUTICS INC | DAMORA.THERAPEUTICS.INC | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 PRIME MEDICINE INC | PRME | 0.04% |
 REGENXBIO INC | RGNX | 0.04% |
 MIMEDX GROUP INC | MDXG | 0.03% |
 OCUGEN INC | OCGN | 0.03% |
 OVID THERAPEUTICS INC | OVID | 0.03% |
 CABALETTA BIO INC | CABA | 0.03% |
 COMPASS THERAPEUTICS INC | CMPX | 0.03% |
 PROTHENA CORP PLC | PRTA | 0.03% |
 MYRIAD GENETICS INC | MYGN | 0.03% |
 EMERGENT BIOSOLUTIONS INC | EBS | 0.03% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.03% |
 PERSPECTIVE THERAPEUTICS INC | CATX | 0.03% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 LEXEO THERAPEUTICS INC | LXEO | 0.02% |
 ACHIEVE LIFE SCIENCES INC | ACHV | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 DREYFUS TRSRY SECURITIES CASH MGMT | DREYFUS.TRSRY.SECURITIES.CASH.MGMT | 0.01% |
 MAPLIGHT THERAPEUTICS INC | MPLT | 0.01% |
 SIONNA THERAPEUTICS INC | SION | 0.01% |
 BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 0.01% |
 OMNIAB INC - 15.00 EARNOUT | 2200964 | 0% |
 INHIBRX INC CVR | INHIBRX.INC.CVR | 0% |
 VERVE THERAPEUTICS INC (CVR) | VERVE.THERAPEUTICS.INC..CVR. | 0% |
 NOVOB DC CVR | NOVOB.DC.CVR | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.22% |
|
Financials | 0.78% |
Direxion Daily S&P Biotech Bull 3X Shares (LABU) share price today is $269.82.
Yes, Indians can buy shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. To buy LABU from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Direxion Daily S&P Biotech Bull 3X Shares (LABU) on Vested. You can start investing in Direxion Daily S&P Biotech Bull 3X Shares (LABU) with a minimum investment of $1.
The 52-week high price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $341.93. The 52-week low price of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is $80.88.
The stock symbol (or ticker) of Direxion Daily S&P Biotech Bull 3X Shares is LABU.
Yes, you can setup SIP in Direxion Daily S&P Biotech Bull 3X Shares shares. Follow the below steps to create the SIP:
Here is the historical performance of LABU on the Vested app.
The expense ratio of Direxion Daily S&P Biotech Bull 3X Shares (LABU) is 0.96%.
Link copied 
